Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction-associated fatty liver disease in Korea.
Mimi KimEileen L YoonSeon ChoChul-Min LeeBo-Kyeong KangHuiyul ParkDae Won JunEun-Hee NahPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
The sex- and age-standardized prevalence of advanced fibrosis was 3.0% (range: 2.6-4.6%) in subjects with MAFLD.
Keyphrases